In the latest close session, Novo Nordisk (NVO) was up +1.89% at $71.01. The stock exceeded the S&P 500, which registered a gain of 0.28% for the day. Meanwhile, the Dow gained 0.43%, and the Nasdaq, a tech-heavy index, added 0.09%. Shares of the drugmaker have depreciated by 11.48% over the course of the past month, underperforming the Medical sector's gain of 0.24%, and the S&P 500's gain of 4.37%.The upcoming earnings release of Novo Nordisk will be of great interest to investors. The company is predicte ...